Aqueous-humor biomarkers and real-world efficacy of conbercept for diabetic macular edema: a prospective study in elderly patients. [PDF]
Front Endocrinol (Lausanne)Xie M.
europepmc +1 more source
Baseline microperimetry and metabolic status predict functional outcomes in diabetic macular oedema: a prospective cohort study of anti-VEGF therapy. [PDF]
Ann MedDeng WL +5 more
europepmc +1 more source
Impact of a structured patient engagement program on treatment adherence, injection persistence, and visual outcomes in real-world anti-VEGF therapy for neovascular age-related macular degeneration. [PDF]
BMC OphthalmolLan L, Lan J, Ren X, Ye B.
europepmc +1 more source
Serum microRNA-34a as a circulating biomarker for age-related macular degeneration and short-term anti-VEGF response in neovascular AMD. [PDF]
BMC OphthalmolKong M, Jin R, Cheng T, Sun L, Tong N.
europepmc +1 more source
Related searches:
Effect of Conbercept on Corneal Neovascularization in a Rabbit Model
Seminars in Ophthalmology, 2023To study the efficacy of Conbercept for the treatment of corneal neovascularization (NV) in a rabbit model.NV was induced by placing sutures. Eight rabbits were used as a control. The other 136 rabbits were randomly divided into two equal groups, and 68 rabbits in each group were divided into four subgroups and given different treatments.
Xinyi Wu, Liqun Du
exaly +3 more sources
AbstractPurposeTo compare the effectiveness of intravitreal conbercept and ranibizumab treatment for retinopathy of prematurity (ROP).MethodsIn this retrospective study, the date of patients with ROP treated with intravitreal conbercept or ranibizumab from July 2012 to March 2018 with at least 12 months of follow‐up at the Eye Center in People’s ...
Jianhong Liang, Jianhong Liang
exaly +3 more sources
BackgroundData on serum vascular endothelial growth factor (VEGF) and drug levels in patients with retinopathy of prematurity (ROP) following intravitreal injections of conbercept (IVC) are lacking.MethodsMulticentre, prospective, non-randomised study of patients with aggressive posterior retinopathy of prematurity (APROP) or type 1 ROP who had not ...
Yong Cheng +6 more
openaire +2 more sources
Anti-inflammatory activities of a new VEGF blocker, Conbercept
Immunopharmacology and Immunotoxicology, 2021Angiogenesis and inflammation exhibit a mutually reinforcing relationship in many human diseases. Vascular endothelial growth factor (VEGF) is one of the most important proangiogenic mediators. Conbercept is a novel VEGF inhibitor.Type II collagen-induced rat rheumatoid arthritis (CIA) model was established to evaluate the anti-chronic inflammation ...
Yang, Liu, Hua, Fu, Li, Zuo
openaire +2 more sources